Treatment

Rate

Site

1

Site

3

Site

5

Site

1

Site

3

Site

5

Site

1

Site

3

Site

5

g a∙i∙ ha⁻¹

%

#m⁻²

g∙m⁻²

Untreated Control

5.7ab

64.8b

74.2c

0.5a

14.6bcd

65.6b

Pendimethalin

1000

55abc

20b

0b

3.5ab

71.7b

58.9c

0.3a

31.3d

98.7b

Dimethenamid-P

544

28c

46b

0b

11.0b

50.6b

43.1bc

5.8a

19.8cd

66.9b

Pethoxamid

840

31c

54b

1b

4.3ab

34.4b

38.4bc

0.8a

9.9abcd

46.6b

Pyroxasulfone

125

62abc

45b

0b

1.1ab

28.4b

20.1b

1.0a

17.1cd

45.6b

S-metolachlor

1050

43bc

40b

0b

10.8b

71.2b

79.8c

3.7a

33.4d

82.4b

Isoxaflutole + Metribuzin

52.5 +210

82abc

97a

100a

0.4ab

0.6a

0.01a

1.1a

0.5a

0.02a

Isoxaflutole + Metribuzin

79 + 315

90abc

99a

100a

0.4ab

0.2a

0.01a

0.2a

0.8ab

0.02a

Isoxaflutole + Metribuzin

105 + 420

98ab

100a

100a

0.4ab

0.02a

0.01a

0.3a

0.1a

0.02a

Pendimethalin + Isoxaflutole + Metribuzin

1000 + 52.5 + 210

66abc

99a

99a

0.6ab

0.6a

0.2a

0.8a

2.2abc

0.1a

Dimethenamid-P + Isoxaflutole + Metribuzin

544 + 52.5 + 210

100a

98a

100a

0.1a

0.02a

0.01a

0.1a

0.1a

0.02a

Pethoxamid + Isoxaflutole + Metribuzin

840 + 52.5 + 210

90abc

97a

100a

0.7ab

0.7a

0.01a

1.3a

2.0abc

0.02a

Pyroxasulfone + Isoxaflutole + Metribuzin

125 + 52.5 + 210

95ab

100a

100a

1.0ab

0.7a

0.01a

3.2a

1.9abc

0.02a

S-metolachlor + Isoxaflutole + Metribuzin

1050 + 52.5 + 210

98ab

98a

98a

1.2ab

0.2a

0.3a

0.9a

1.3abc

0.2a